Healthcare & Life Sciences / Drug R&D Tech
Best Computational Platforms For Drug Formulation Companies
What is Computational Platforms For Drug Formulation?
The computational platforms for drug formulation market encompasses AI and machine learning platforms that optimize drug delivery systems and formulation design. These solutions focus on nanoparticle-based delivery design, tablet formulation optimization, high-throughput formulation screening, and solubility enhancement. Key technologies combine AI with advanced computational methods to enhance drug targeting, bioavailability, stability prediction, and manufacturing efficiency. This market primarily serves pharmaceutical companies and biotechnology firms developing novel drug delivery systems and formulations.
Expert Collections
Market Map
Similar Markets
Do you compete within Computational Platforms For Drug Formulation?
Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.
Top Computational Platforms For Drug Formulation Companies
METiS Technologies engages in AI-driven drug formulation within the pharmaceutical industry. The company uses machine learning, quantum simulation, and high-throughput experimentation to develop drug candidates. METiS Technologies serves the pharmaceutical sector with a focus on drug formulation. It was founded in 2020 and is based in Hangzhou, China.
Known Partners
Key People
Wenshou Wang, Caida Lai, Chris Lai, and 2 more
Canada / Founded Year: 0000
Intrepid Labs serves as a biotechnology company focused on the development of therapeutics through technology. The company specializes in designing next-generation drug products using machine learning, robotics, and pharmaceutical expertise to enhance drug properties and performance. Intrepid Labs serves sectors within the pharmaceutical and biotechnology industries. It was founded in 2023 and is based in Toronto, Canada.
Key People
Subscribe, Subscribe
All Companies in Computational Platforms For Drug Formulation
Dyno Therapeutics develops a biotechnology platform. It applies artificial intelligence (AI) and quantitative high-throughput in vivo experiments to develop gene therapy. It enables medical researchers to access novel adeno-associated virus (AAV) vectors, facilitating targeted delivery for new gene therapies. The company was founded in 2018 and is based in Watertown, Massachusetts.
Known Partners
Subscribe, Subscribe, Subscribe
Key People
Subscribe, Subscribe, Subscribe, and 2 more
Israel / Founded Year: 0000
Mana.bio operates as an artificial intelligence-based drug delivery startup company. It creates a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including ribonucleic acid (RNA)-based therapeutics, vaccines, and gene therapy. The company uses technology powered by machine learning and nanotechnology to identify formulations of lipid nanoparticle drug delivery systems and focus on gene therapy. It was founded in 2021 and is based in Tel Aviv, Israel.
Known Partners
Subscribe, Subscribe
Key People
Subscribe, Subscribe
United States / Founded Year: 0000
Persist AI is a company specializing in AI-driven drug formulation development within the pharmaceutical industry. The company offers services such as high-throughput screening of drug formulations, cloud-based formulation laboratories, and automated aseptic manufacturing. Persist AI primarily serves drug manufacturers and contract research organizations (CROs) in the pharmaceutical sector. It was founded in 2022 and is based in West Sacramento, California.
Key People
Subscribe, Subscribe
United Kingdom / Founded Year: 0000
ViaNautis focuses on the development of genetic nanomedicines in the biotechnology industry. The company's main service involves using its technology a nanovesicle platform that uses advanced polymer materials and machine learning to direct nucleic acid therapeutics to specific sites of action, focusing on hard-to-reach areas such as the brain and lungs. ViaNautis formerly known as SomaServe. It was founded in 2018 and is based in Cambridge, United Kingdom.
Known Partners
Subscribe
Key People
Subscribe, Subscribe
Our Methodology
The ESP matrix leverages data and analyst insight to identify and rank leading private-market companies in a given technology landscape.
What is Computational Platforms For Drug Formulation?
The computational platforms for drug formulation market encompasses AI and machine learning platforms that optimize drug delivery systems and formulation design. These solutions focus on nanoparticle-based delivery design, tablet formulation optimization, high-throughput formulation screening, and solubility enhancement. Key technologies combine AI with advanced computational methods to enhance drug targeting, bioavailability, stability prediction, and manufacturing efficiency. This market primarily serves pharmaceutical companies and biotechnology firms developing novel drug delivery systems and formulations.
Expert Collections
Market Map
Similar Markets
Do you compete within Computational Platforms For Drug Formulation?
Reach more buyers.
Your future customers are researching their next tech solution on CB Insights. Make sure they can find you.